Multi-cohort validation of a semaphorin prognostic signature to identify an immune- excluded subtype and therapeutic sensitivity in lung adenocarcinoma.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162680778
Cites:
Cited by:
Related to:
